Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Aug 03, 2009 3:53pm
142 Views
Post# 16187169

ok, I translated

ok, I translated     I don't disagree with anything you said and I thought that AEZ was a good company to take a look at but; I feel that CUR will be in the same place down the road and reaping the benefits of being the first company with an FDA approved prostate test. I am as upset as anyone out there with the current share price and the fact we have not bounced, at least back, to where we were, prior to the announcement of the offering
     John does have the company focused and he will deliver. If you look back at the AEZ boards, they were very upset with the drop that their company took over the last year.
     Gen-Probe will continue to put feet on the ground in Europe pushing PCA3 and will we see them continue to ramp up, that will eventually lead to a launch off; once PCA3 is FDA approved. Sometime between now and than, investors will start to jump on CUR in anticipation of approval. For now we just need to take the seller out and return to normal trading.
Bullboard Posts